197 related articles for article (PubMed ID: 37142816)
1. ARID1A Inactivation Increases Expression of circ0008399 and Promotes Cisplatin Resistance in Bladder Cancer.
Jiang YK; Shuai YJ; Ding HM; Zhang H; Huang C; Wang L; Sun JY; Wei WJ; Xiao XY; Jiang GS
Curr Med Sci; 2023 Jun; 43(3):560-571. PubMed ID: 37142816
[TBL] [Abstract][Full Text] [Related]
2.
Wei W; Sun J; Zhang H; Xiao X; Huang C; Wang L; Zhong H; Jiang Y; Zhang X; Jiang G
Cancer Res; 2021 Dec; 81(24):6142-6156. PubMed ID: 34702726
[TBL] [Abstract][Full Text] [Related]
3. EIF4A3-mediated biogenesis of circSTX6 promotes bladder cancer metastasis and cisplatin resistance.
Wei W; Liu K; Huang X; Tian S; Wang H; Zhang C; Ye J; Dong Y; An Z; Ma X; Wang B; Huang Y; Zhang X
J Exp Clin Cancer Res; 2024 Jan; 43(1):2. PubMed ID: 38163881
[TBL] [Abstract][Full Text] [Related]
4. Circ_0058063 contributes to cisplatin-resistance of bladder cancer cells by upregulating B2M through acting as RNA sponges for miR-335-5p.
Sun M; Liu X; Zhao W; Zhang B; Deng P
BMC Cancer; 2022 Mar; 22(1):313. PubMed ID: 35321689
[TBL] [Abstract][Full Text] [Related]
5. Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation.
Ni F; Yan CY; Zhou S; Hui PY; Du YH; Zheng L; Yu J; Hu XJ; Zhang ZG
Cancer Chemother Pharmacol; 2018 Oct; 82(4):593-605. PubMed ID: 30032449
[TBL] [Abstract][Full Text] [Related]
6. hsa_circ_0101119 facilitates the progression of cervical cancer via an interaction with EIF4A3 to inhibit TCEAL6 expression.
Sui X; Wang Y; Liu H
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278492
[TBL] [Abstract][Full Text] [Related]
7. CircUGGT2 facilitates progression and cisplatin resistance of bladder cancer through nonhomologous end-joining pathway.
Lyu F; Huang S; Yan Z; He Q; Liu C; Cheng L; Cong Y; Chen K; Song Y; Xing Y
Cell Signal; 2024 Jul; 119():111164. PubMed ID: 38583745
[TBL] [Abstract][Full Text] [Related]
8. HIF-1α-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4.
Yu M; Ozaki T; Sun D; Xing H; Wei B; An J; Yang J; Gao Y; Liu S; Kong C; Zhu Y
J Exp Clin Cancer Res; 2020 Jun; 39(1):108. PubMed ID: 32522234
[TBL] [Abstract][Full Text] [Related]
9. Hsa_circ_0004296 inhibits metastasis of prostate cancer by interacting with EIF4A3 to prevent nuclear export of ETS1 mRNA.
Mao S; Zhang W; Yang F; Guo Y; Wang H; Wu Y; Wang R; Maskey N; Zheng Z; Li C; Ma W; Zhang J; Yan Y; Yao X
J Exp Clin Cancer Res; 2021 Oct; 40(1):336. PubMed ID: 34696782
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of ZBTB11 impedes R-loop elimination and increases the sensitivity to cisplatin by inhibiting DDX1 transcription in bladder cancer.
Chen L; Liu Z; Tang H; Zhou Z; Chen J; Ma Z; Deng M; Li X; Wu Y; Zheng L; Zhou L; Zheng X; Liu Z
Cell Prolif; 2022 Dec; 55(12):e13325. PubMed ID: 36054300
[TBL] [Abstract][Full Text] [Related]
11. Transactivation of PTGS2 by PAX5 signaling potentiates cisplatin resistance in muscle-invasive bladder cancer cells.
Dong BW; Zhang WB; Qi SM; Yan CY; Gao J
Biochem Biophys Res Commun; 2018 Sep; 503(4):2293-2300. PubMed ID: 29964012
[TBL] [Abstract][Full Text] [Related]
12. EIF4A3-mediated hsa_circ_0088088 promotes the carcinogenesis of breast cancer by sponging miR-135-5p.
Liu Q; Dong H
J Biochem Mol Toxicol; 2021 Nov; 35(11):e22909. PubMed ID: 34463003
[TBL] [Abstract][Full Text] [Related]
13. N
Xu C; Zhou J; Zhang X; Kang X; Liu S; Song M; Chang C; Lin Y; Wang Y
Cell Mol Biol Lett; 2024 Feb; 29(1):28. PubMed ID: 38395751
[TBL] [Abstract][Full Text] [Related]
14. Hsa_circ_0030042 regulates abnormal autophagy and protects atherosclerotic plaque stability by targeting eIF4A3.
Yu F; Zhang Y; Wang Z; Gong W; Zhang C
Theranostics; 2021; 11(11):5404-5417. PubMed ID: 33859754
[No Abstract] [Full Text] [Related]
15. EIF4A3-induced circ_0084615 contributes to the progression of colorectal cancer via miR-599/ONECUT2 pathway.
Jiang Z; Tai Q; Xie X; Hou Z; Liu W; Yu Z; Liang Z; Chen S
J Exp Clin Cancer Res; 2021 Jul; 40(1):227. PubMed ID: 34253241
[TBL] [Abstract][Full Text] [Related]
16. EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer.
Okamura S; Yoshino H; Kuroshima K; Tsuruda M; Osako Y; Sakaguchi T; Yonemori M; Yamada Y; Tatarano S; Nakagawa M; Enokida H
BMC Cancer; 2021 Jan; 21(1):48. PubMed ID: 33430801
[TBL] [Abstract][Full Text] [Related]
17. eIF4A3-induced circWAC promotes breast cancer progression through mediating miR-599/E2F3 axis.
Huang WH; Yang Q; Zhang C
Kaohsiung J Med Sci; 2022 Apr; 38(4):321-335. PubMed ID: 34989110
[TBL] [Abstract][Full Text] [Related]
18. Transcribed ultraconserved region Uc.63+ promotes resistance to cisplatin through regulation of androgen receptor signaling in bladder cancer.
Sekino Y; Sakamoto N; Ishikawa A; Honma R; Shigematsu Y; Hayashi T; Sentani K; Oue N; Teishima J; Matsubara A; Yasui W
Oncol Rep; 2019 May; 41(5):3111-3118. PubMed ID: 30864720
[TBL] [Abstract][Full Text] [Related]
19. CircLIFR synergizes with MSH2 to attenuate chemoresistance via MutSα/ATM-p73 axis in bladder cancer.
Zhang H; Xiao X; Wei W; Huang C; Wang M; Wang L; He Y; Sun J; Jiang Y; Jiang G; Zhang X
Mol Cancer; 2021 Apr; 20(1):70. PubMed ID: 33874956
[TBL] [Abstract][Full Text] [Related]
20. circ-SIRT1 Promotes Colorectal Cancer Proliferation and EMT by Recruiting and Binding to eIF4A3.
Wang X; Liu S; Xu B; Liu Y; Kong P; Li C; Li B
Anal Cell Pathol (Amst); 2021; 2021():5739769. PubMed ID: 34660182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
